Florida SB 1638: Homestead Property Tax Exemptions

Bill Text

1638 
Prohibitions Against Discriminatory Practices Relating to 340B Entities and 340B Drugs 
2026-01-09T08:41:31Z 
Prohibiting drug manufacturers from engaging in certain acts relating to the acquisition of 340B drugs by and the delivery of such drugs to specified pharmacies; prohibiting health insurance issuers, pharmacy benefit managers, and other third-party payors, and agents thereof, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs; prohibiting individual health insurers, group, blanket, and franchise health insurers, and health maintenance organizations, respectively, and pharmacy benefit managers on behalf of such insurers and health maintenance organizations, from engaging in certain discriminatory acts relating to reimbursement to 340B entities for 340B drugs, etc. 
Original Filed Version 
2026 
S 
2026-07-01T00:00:00Z 
GB 
General Bill 
__ 

 Florida Senate - 2026 SB 1638 

 By Senator Jones 

 34-00322-26 20261638__ 
 1 A bill to be entitled 
 2 An act relating to prohibitions against discriminatory 
 3 practices relating to 340B entities and 340B drugs; 
 4 providing a short title; creating s. 499.061, F.S.; 
 5 providing definitions; prohibiting drug manufacturers 
 6 from engaging in certain acts relating to the 
 7 acquisition of 340B drugs by and the delivery of such 
 8 drugs to specified pharmacies; providing an exception; 
 9 prohibiting drug manufacturers from interfering with 
 10 pharmacies’ rights to contract with 340B entities; 
 11 providing that each commission of certain acts 
 12 constitutes a violation of the Florida Deceptive and 
 13 Unfair Trade Practices Act and subjects the violator 
 14 to certain actions and penalties; providing 
 15 construction and applicability; creating s. 626.8829, 
 16 F.S.; providing definitions; prohibiting health 
 17 insurance issuers, pharmacy benefit managers, and 
 18 other third-party payors, and agents thereof, from 
 19 engaging in certain discriminatory acts relating to 
 20 reimbursement to 340B entities for 340B drugs; 
 21 providing applicability; providing that each 
 22 commission of certain acts constitutes a violation of 
 23 the Florida Deceptive and Unfair Trade Practices Act 
 24 and subjects the violator to certain actions and 
 25 penalties; providing construction; creating ss. 
 26 627.64743, 627.65733, and 641.31543, F.S.; providing 
 27 definitions; prohibiting individual health insurers, 
 28 group, blanket, and franchise health insurers, and 
 29 health maintenance organizations, respectively, and 
 30 pharmacy benefit managers on behalf of such insurers 
 31 and health maintenance organizations, from engaging in 
 32 certain discriminatory acts relating to reimbursement 
 33 to 340B entities for 340B drugs; providing 
 34 applicability; providing that each commission of 
 35 certain acts constitutes a violation of the Florida 
 36 Deceptive and Unfair Trade Practices Act and subjects 
 37 the violator to certain actions and penalties; 
 38 providing construction; providing an effective date. 
 39 
 40 Be It Enacted by the Legislature of the State of Florida: 
 41 
 42 Section 1. This act may be cited as the “Defending 
 43 Affordable Prescription Drug Costs Act.” 
 44 Section 2. Section 499.061, Florida Statutes, is created to 
 45 read: 
 46 499.061 Prohibitions against manufacturers’ discriminatory 
 47 practices relating to 340B drugs and 340B entities.— 
 48 (1) As used in this section, the term: 
 49 (a) “340B drug” means a drug that has been subject to any 
 50 offer for reduced prices by a manufacturer pursuant to 42 U.S.C. 
 51 s. 256b and is purchased by a covered entity as defined in 42 
 52 U.S.C. s. 256b(a)(4). 
 53 (b) “340B entity” means an entity participating or 
 54 authorized to participate in the 340B Drug Pricing Program, as 
 55 described in 42 U.S.C. s. 256b, including its pharmacy, or any 
 56 pharmacy contracted with the participating entity to dispense 
 57 drugs purchased through the 340B Drug Pricing Program. 
 58 (2) A manufacturer may not: 
 59 (a) Deny, restrict, prohibit, or otherwise interfere with, 
 60 directly or indirectly, the acquisition of a 340B drug by, or 
 61 delivery of a 340B drug to, a pharmacy that is under contract 
 62 with a 340B entity and is authorized under such contract to 
 63 receive and dispense 340B drugs on behalf of the covered entity 
 64 unless such receipt is prohibited by the United States 
 65 Department of Health and Human Services; or 
 66 (b) Interfere with a pharmacy’s right to contract with a 
 67 340B entity. 
 68 (3) The commission of any act prohibited by this section is 
 69 a deceptive and unfair trade practice and constitutes a 
 70 violation of the Florida Deceptive and Unfair Trade Practices 
 71 Act under part II of chapter 501, and subjects the violator to 
 72 all actions, including, but not limited to, investigative 
 73 demands, remedies, and penalties, provided for in the Florida 
 74